Oncology Biosimilar Market Report

China Oncology Biosimilar Industry Market Research Report 2023-2029

  • POSTDATE：Oct 09, 2023
  • PAGES：218
  • REPORT CODE：GMM1840274
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oncology Biosimilar industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Mylan

    • Baxter

    • Dr Reddy's Laboratories

    • Sandoz

    • Allergan

    • Amgen

    • BioXpress Therapeutics

    • AbbVie

    • F Hoffmann-La Roche

    • Boehringer Ingelheim

    • Biogen

    • AstraZeneca

    • Biocon

    By Type:

    • Hormones

    • Uucleic Acids

    • Protein

    By Application:

    • Application 1

    • Application 2

    • Application 3

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oncology Biosimilar Market Overview 2018-2029

    • 1.1 China Oncology Biosimilar Industry Development Overview

    • 1.2 China Oncology Biosimilar Industry Development History

    • 1.3 China Oncology Biosimilar Industry Market Size (2018-2029)

    • 1.4 China Oncology Biosimilar Market Analysis by Type from Production Side

      • 1.4.1 China Oncology Biosimilar Production Volume, Production Value and Growth Rate of Hormones (2018-2029)

      • 1.4.2 China Oncology Biosimilar Production Volume, Production Value and Growth Rate of Uucleic Acids (2018-2029)

      • 1.4.3 China Oncology Biosimilar Production Volume, Production Value and Growth Rate of Protein (2018-2029)

    • 1.5 China Oncology Biosimilar Market Analysis by Application from Consumption End

      • 1.5.1 China Oncology Biosimilar Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

      • 1.5.2 China Oncology Biosimilar Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

      • 1.5.3 China Oncology Biosimilar Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • 1.6 China Oncology Biosimilar Market Analysis by Region

      • 1.6.1 North China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oncology Biosimilar Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oncology Biosimilar Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oncology Biosimilar Market Status and Competition Analysis in 2023

      • 2.2.3 China Oncology Biosimilar Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oncology Biosimilar Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oncology Biosimilar Industry Development

    Chapter 3 Oncology BiosimilarIndustry Chain Analysis

    • 3.1 Oncology Biosimilar Industry Chain

    • 3.2 Oncology Biosimilar Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oncology Biosimilar Market

    • 3.3 Oncology Biosimilar Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oncology Biosimilar Market

    Chapter 4 China Oncology Biosimilar Market, by Type

    • 4.1 China Oncology Biosimilar Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oncology Biosimilar Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oncology Biosimilar Production Volume and Growth Rate, by Type

      • 4.5.1 China Oncology Biosimilar Production Volume and Growth Rate of Hormones

      • 4.5.2 China Oncology Biosimilar Production Volume and Growth Rate of Uucleic Acids

      • 4.5.3 China Oncology Biosimilar Production Volume and Growth Rate of Protein

    Chapter 5 China Oncology Biosimilar Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oncology Biosimilar Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oncology Biosimilar Market Size and Growth Rate, by Application

      • 5.5.1 China Oncology Biosimilar Market Size and Growth Rate of Application 1

      • 5.5.2 China Oncology Biosimilar Market Size and Growth Rate of Application 2

      • 5.5.3 China Oncology Biosimilar Market Size and Growth Rate of Application 3

    Chapter 6 China Oncology Biosimilar Market, by Region

    • 6.1 China Oncology Biosimilar Production Volume and Production Value, by Region

    • 6.2 China Oncology Biosimilar Sales Volume and Sales Value, by Region

    Chapter 7 North China Oncology Biosimilar Market Analysis

    • 7.1 North China Oncology Biosimilar Market, by Type

    • 7.2 North China Oncology Biosimilar Market, by Application

    Chapter 8 Central China Oncology Biosimilar Market Analysis

    • 8.1 Central China Oncology Biosimilar Market, by Type

    • 8.2 Central China Oncology Biosimilar Market, by Application

    Chapter 9 South China Oncology Biosimilar Market Analysis

    • 9.1 South China Oncology Biosimilar Market, by Type

    • 9.2 South China Oncology Biosimilar Market, by Application

    Chapter 10 East China Oncology Biosimilar Market Analysis

    • 10.1 East China Oncology Biosimilar Market, by Type

    • 10.2 East China Oncology Biosimilar Market, by Application

    Chapter 11 Northeast China Oncology Biosimilar Market Analysis

    • 11.1 Northeast China Oncology Biosimilar Market, by Type

    • 11.2 Northeast China Oncology Biosimilar Market, by Application

    Chapter 12 Southwest China Oncology Biosimilar Market Analysis

    • 12.1 Southwest China Oncology Biosimilar Market, by Type

    • 12.2 Southwest China Oncology Biosimilar Market, by Application

    Chapter 13 Northwest China Oncology Biosimilar Market Analysis

    • 13.1 Northwest China Oncology Biosimilar Market, by Type

    • 13.2 Northwest China Oncology Biosimilar Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Mylan

        • 14.1.1 Mylan Company Profile

        • 14.1.2 Mylan Oncology Biosimilar Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Baxter

        • 14.2.1 Baxter Company Profile

        • 14.2.2 Baxter Oncology Biosimilar Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Dr Reddy's Laboratories

        • 14.3.1 Dr Reddy's Laboratories Company Profile

        • 14.3.2 Dr Reddy's Laboratories Oncology Biosimilar Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Sandoz

        • 14.4.1 Sandoz Company Profile

        • 14.4.2 Sandoz Oncology Biosimilar Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Allergan

        • 14.5.1 Allergan Company Profile

        • 14.5.2 Allergan Oncology Biosimilar Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Amgen

        • 14.6.1 Amgen Company Profile

        • 14.6.2 Amgen Oncology Biosimilar Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 BioXpress Therapeutics

        • 14.7.1 BioXpress Therapeutics Company Profile

        • 14.7.2 BioXpress Therapeutics Oncology Biosimilar Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 AbbVie

        • 14.8.1 AbbVie Company Profile

        • 14.8.2 AbbVie Oncology Biosimilar Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 F Hoffmann-La Roche

        • 14.9.1 F Hoffmann-La Roche Company Profile

        • 14.9.2 F Hoffmann-La Roche Oncology Biosimilar Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Boehringer Ingelheim

        • 14.10.1 Boehringer Ingelheim Company Profile

        • 14.10.2 Boehringer Ingelheim Oncology Biosimilar Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Biogen

        • 14.11.1 Biogen Company Profile

        • 14.11.2 Biogen Oncology Biosimilar Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 AstraZeneca

        • 14.12.1 AstraZeneca Company Profile

        • 14.12.2 AstraZeneca Oncology Biosimilar Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Biocon

        • 14.13.1 Biocon Company Profile

        • 14.13.2 Biocon Oncology Biosimilar Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oncology Biosimilar Industry Research Conclusions

    • 15.2 Oncology Biosimilar Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oncology Biosimilar Industry Market Size (2018-2029)

    • Figure China Oncology Biosimilar Production Volume, Production Value and Growth Rate of Hormones (2018-2029)

    • Figure China Oncology Biosimilar Production Volume, Production Value and Growth Rate of Uucleic Acids (2018-2029)

    • Figure China Oncology Biosimilar Production Volume, Production Value and Growth Rate of Protein (2018-2029)

    • Figure China Oncology Biosimilar Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)

    • Figure China Oncology Biosimilar Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)

    • Figure China Oncology Biosimilar Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)

    • Figure North China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    • Figure Central China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    • Figure South China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    • Figure East China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oncology Biosimilar Market Size and Growth Rate from 2018-2029

    • Figure Oncology Biosimilar Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oncology Biosimilar Market Share by Type in 2018

    • Figure China Oncology Biosimilar Market Share by Type in 2023

    • Figure China Oncology Biosimilar Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oncology Biosimilar Production Volume and Growth Rate of Hormones (2018-2023)

    • Figure China Oncology Biosimilar Production Volume and Growth Rate of Uucleic Acids (2018-2023)

    • Figure China Oncology Biosimilar Production Volume and Growth Rate of Protein (2018-2023)

    • Figure China Oncology Biosimilar Market Share by Application in 2018

    • Figure China Oncology Biosimilar Market Share by Application in 2023

    • Figure China Oncology Biosimilar Total Market Size and Growth Rate from Consumption End

    • Figure China Oncology Biosimilar Market Size and Growth Rate of Application 1 (2018-2023)

    • Figure China Oncology Biosimilar Market Size and Growth Rate of Application 2 (2018-2023)

    • Figure China Oncology Biosimilar Market Size and Growth Rate of Application 3 (2018-2023)

    • Table China Oncology Biosimilar Production Volume by Region (2018-2023)

    • Table China Oncology Biosimilar Production Volume Share by Region (2018-2023)

    • Figure China Oncology Biosimilar Production Volume Share by Region (2018-2023)

    • Table China Oncology Biosimilar Production Value by Region (2018-2023)

    • Table China Oncology Biosimilar Production Value Share by Region (2018-2023)

    • Figure China Oncology Biosimilar Production Value Share by Region (2018-2023)

    • Table China Oncology Biosimilar Sales Volume by Region (2018-2023)

    • Table China Oncology Biosimilar Sales Volume Share by Region (2018-2023)

    • Figure China Oncology Biosimilar Sales Volume Share by Region (2018-2023)

    • Table China Oncology Biosimilar Sales Value by Region (2018-2023)

    • Table China Oncology Biosimilar Sales Value Share by Region (2018-2023)

    • Figure China Oncology Biosimilar Sales Value Share by Region (2018-2023)

    • Table North China Oncology Biosimilar Production Volume by Type (2018-2023)

    • Table North China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Figure North China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Table North China Oncology Biosimilar Sales Volume by Application (2018-2023)

    • Table North China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Figure North China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Table Central China Oncology Biosimilar Production Volume by Type (2018-2023)

    • Table Central China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Figure Central China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Table Central China Oncology Biosimilar Sales Volume by Application (2018-2023)

    • Table Central China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Figure Central China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Table South China Oncology Biosimilar Production Volume by Type (2018-2023)

    • Table South China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Figure South China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Table South China Oncology Biosimilar Sales Volume by Application (2018-2023)

    • Table South China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Figure South China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Table East China Oncology Biosimilar Production Volume by Type (2018-2023)

    • Table East China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Figure East China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Table East China Oncology Biosimilar Sales Volume by Application (2018-2023)

    • Table East China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Figure East China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oncology Biosimilar Production Volume by Type (2018-2023)

    • Table Northeast China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Table Northeast China Oncology Biosimilar Sales Volume by Application (2018-2023)

    • Table Northeast China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oncology Biosimilar Production Volume by Type (2018-2023)

    • Table Southwest China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Table Southwest China Oncology Biosimilar Sales Volume by Application (2018-2023)

    • Table Southwest China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oncology Biosimilar Production Volume by Type (2018-2023)

    • Table Northwest China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oncology Biosimilar Production Volume Share by Type (2018-2023)

    • Table Northwest China Oncology Biosimilar Sales Volume by Application (2018-2023)

    • Table Northwest China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oncology Biosimilar Sales Volume Share by Application (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Baxter Company Profile

    • Table Baxter Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Dr Reddy's Laboratories Company Profile

    • Table Dr Reddy's Laboratories Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Sandoz Company Profile

    • Table Sandoz Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Amgen Company Profile

    • Table Amgen Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table BioXpress Therapeutics Company Profile

    • Table BioXpress Therapeutics Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table AbbVie Company Profile

    • Table AbbVie Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Company Profile

    • Table F Hoffmann-La Roche Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim Company Profile

    • Table Boehringer Ingelheim Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Biogen Company Profile

    • Table Biogen Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Oncology Biosimilar Revenue, Price and Gross (2018-2023)

    • Table Biocon Company Profile

    • Table Biocon Oncology Biosimilar Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US